Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP.

Circulation. 2001 Oct 30;104(18):2205-9.

2.

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators..

N Engl J Med. 2005 Jun 9;352(23):2389-97.

3.
4.

Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis.

De Vecchis R, Di Biase G, Esposito C, Ciccarelli A, Cioppa C, Giasi A, Ariano C, Cantatrione S.

J Cardiovasc Med (Hagerstown). 2013 Aug;14(8):559-67. doi: 10.2459/JCM.0b013e3283587267. Review.

PMID:
23032960
5.

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.

Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M.

J Am Coll Cardiol. 2002 Nov 20;40(10):1723-30.

6.

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.

Andrews TC, Ballantyne CM, Hsia JA, Kramer JH.

Am J Med. 2001 Aug 15;111(3):185-91.

PMID:
11530028
7.

Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?

Parolari A, Tremoli E, Cavallotti L, Trezzi M, Kassem S, Loardi C, Veglia F, Ferrari G, Pacini D, Alamanni F.

Heart. 2011 Apr;97(7):523-9. doi: 10.1136/hrt.2010.215046. Review.

PMID:
21270077
8.

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.

Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M, Binder T, Maurer G, Baumgartner H.

Circulation. 2004 Sep 7;110(10):1291-5. Review.

9.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.

Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669.

PMID:
18345946
10.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031
11.

Effect of statins on the progression of bioprosthetic aortic valve degeneration.

Antonini-Canterin F, Zuppiroli A, Popescu BA, Granata G, Cervesato E, Piazza R, Pavan D, Nicolosi GL.

Am J Cardiol. 2003 Dec 15;92(12):1479-82.

PMID:
14675593
13.

Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).

Dichtl W, Alber HF, Feuchtner GM, Hintringer F, Reinthaler M, Bartel T, Süssenbacher A, Grander W, Ulmer H, Pachinger O, Müller S.

Am J Cardiol. 2008 Sep 15;102(6):743-8. doi: 10.1016/j.amjcard.2008.04.060.

PMID:
18774000
14.

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.

Foody JM, Rathore SS, Galusha D, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM.

J Am Geriatr Soc. 2006 Mar;54(3):421-30.

15.

Comparison of ascending aortic size in patients with severe bicuspid aortic valve stenosis treated with versus without a statin drug.

Goel SS, Tuzcu EM, Agarwal S, Aksoy O, Krishnaswamy A, Griffin BP, Svensson LG, Kapadia SR.

Am J Cardiol. 2011 Nov 15;108(10):1458-62. doi: 10.1016/j.amjcard.2011.06.071.

PMID:
22040719
16.
17.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-Rubió P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
18.

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gonçalves F, Rajamannan NM.

J Am Coll Cardiol. 2007 Feb 6;49(5):554-61.

19.

Hydroxymethylglutaryl coenzyme-a reductase inhibitors delay the progression of rheumatic aortic valve stenosis a long-term echocardiographic study.

Antonini-Canterin F, Leiballi E, Enache R, Popescu BA, Roşca M, Cervesato E, Piazza R, Ginghină C, Nicolosi GL.

J Am Coll Cardiol. 2009 May 19;53(20):1874-9. doi: 10.1016/j.jacc.2009.01.064.

20.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
Items per page

Supplemental Content

Support Center